Autologous hematopoietic stem cell transplantation in patients with end-stage liver disease: a 5-year follow-up study of 48 patients.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Review for Medical and Pharmacological Sciences

• Publication date

  2016-07-01

• Fields of study

  Medicine

• Identifiers
  PMID 27424993
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bone marrow-derived mesenchymal stem cell therapy for decompensated liver cirrhosis: a meta-analysis.

  2014cited by this paper
• Clinical outcome of autologous hematopoietic stem cell infusion via hepatic artery or portal vein in patients with end-stage liver diseases.

  2014cited by this paper
• Indocyanine green clearance test combined with MELD score in predicting the short-term prognosis of patients with acute liver failure.

  2014cited by this paper
• Bone marrow derived stem cells for the treatment of end-stage liver disease.

  2014cited by this paper
• Likelihood of Malignancy in Gallbladder Polyps and Outcomes Following Cholecystectomy in Primary Sclerosing Cholangitis

  2012cited by this paper
• Autologous bone marrow cell infusions suppress tumor initiation in hepatocarcinogenic mice with liver cirrhosis

  2012cited by this paper
• Stem cell therapy in chronic liver disease

  2012cited by this paper
• Autologous bone marrow cell infusions suppress tumor initiation in hepatocarcinogenic mice with liver cirrhosis

  2012cited by this paper
• Which score system can best predict recipient outcomes after living donor liver transplantation?

  2012cited by this paper
• Noninvasive Evaluation of Liver Fibrosis in Patients with Chronic Hepatitis C

  2011cited by this paper
• Adipose tissue-derived mesenchymal stem cells and hepatic differentiation: old concepts and future perspectives.

  2011cited by this paper
• Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short‐term and long‐term outcomes

  2011cited by this paper
• Organogenesis and development of the liver.

  2010cited by this paper
• Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients

  2010cited by this paper
• Stem cells and hepatic cirrhosis.

  2010cited by this paper
• Autologous Hematopoietic Stem Cell Transplantation in 48 Patients with End-Stage Chronic Liver Diseases

  2010cited by this paper
• Autologous Bone Marrow Infusion Activates the Progenitor Cell Compartment in Patients with Advanced Liver Cirrhosis

  2010cited by this paper
• Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease.

  2010cited by this paper
• Autologous Infusion of Expanded Mobilized Adult Bone Marrow-Derived CD34+ Cells Into Patients With Alcoholic Liver Cirrhosis

  2008cited by this paper
• Indications of liver transplantation in patients with complications of cirrhosis.

  2007cited by this paper
• Long‐term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease

  2007cited by this paper
• Characterization and Clinical Application of Human CD34+ Stem/Progenitor Cell Populations Mobilized into the Blood by Granulocyte Colony‐Stimulating Factor

  2006cited by this paper
• Helicobacter pylori and hepatocellular carcinoma: Correlated or uncorrelated?

  2006cited by this paper
• Liver fibrosis.

  2005cited by this paper
• Cell-based therapy for liver diseases.

  2003cited by this paper
• Grading and staging the histopathological lesions of chronic hepatitis: The Knodell histology activity index and beyond

  2000cited by this paper
• Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease

  1999cited by this paper

• Umbilical cord blood-derived mesenchymal stem cells transplantation decreases incidence of liver cancer in end-stage liver disease patients: a retrospective analysis over 5 years.

  2021cites this paper
• Machine Learning in the Prediction of Costs forLiver Transplantation

  2017cites this paper